Explain the role of platelet dose in pediatric transfusion outcomes from the PLADO study.
Elaborate on the safety issues with the Intecept pathogen inactivation system as applied to pediatric platelet transfusion.
Determine the role of T-activation in atypical hemolytic uremic syndrome.
Explain the issues surrounding the use of DEHP in pediatric transfusion products.
CE Category
CE Value
California Clinical Laboratory Personnel
1.5
California Nurse
1.8
Florida Laboratory Personnel
1.8
General Attendee
1.5
Physician
1.5
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.